DoH slated for 'cheap' HPV jab choice

Girls in the UK could be left at higher risk of genital warts than those in the rest of the Western world after the DoH have decided to purchase the cheapest HPV jab.

Charities have condemned the DoH decision to award the contract to GlaxoSmithKline for Cervarix - a vaccine that protects against HPV strains 16 and 18.

Many expected the UK to follow the lead of the rest of Western Europe, the USA, Canada, Australia and New Zealand and purchase the quadravalent vaccine Gardasil. By also protecting against HPV strains 6 and 11, which cause genital warts.

Lisa Power, head of policy at the Terrence Higgins Trust, said the DoH decision was short sighted.

‘They are saving pennies to spend pounds later,' she said.

‘Most European countries have taken the sensible decision to protect their population from both cervical cancer and genital warts simultaneously, but it seeems that the UK is fated to be not just the poor man of Europe but also the warty one.'

From September, schoolgirls aged 12 and 13 will receive the vaccine, with a catch-up campaign from 2009 for those aged 14 to 18.

rachel.liddle@haymarket.com

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus